Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| HIBBS KATHY L | May 2, 2024 | Sell | 38,551 | $0.4941 | $19,000 |
| HIBBS KATHY L | Apr 18, 2024 | Sell | 38,548 | $0.4708 | $18,000 |
| HIBBS KATHY L | Apr 4, 2024 | Sell | 38,548 | $0.5002 | $19,000 |
| HIBBS KATHY L | Mar 21, 2024 | Sell | 38,548 | $0.4642 | $18,000 |
| HIBBS KATHY L | Mar 7, 2024 | Sell | 38,548 | $0.53 | $20,000 |
| HIBBS KATHY L | Feb 22, 2024 | Sell | 38,548 | $0.6051 | $23,000 |
| HIBBS KATHY L | Feb 15, 2024 | Sell | 38,548 | $0.7837 | $30,000 |
| HIBBS KATHY L | Jan 25, 2024 | Sell | 38,548 | $0.7263 | $28,000 |
| HIBBS KATHY L | Jan 11, 2024 | Sell | 38,548 | $0.7155 | $28,000 |
| HIBBS KATHY L | Dec 28, 2023 | Sell | 38,548 | $0.9314 | $36,000 |
| HIBBS KATHY L | Dec 14, 2023 | Sell | 38,548 | $0.9656 | $37,000 |
| HIBBS KATHY L | Nov 30, 2023 | Sell | 38,548 | $0.8756 | $34,000 |
| HIBBS KATHY L | Nov 16, 2023 | Sell | 38,548 | $0.7713 | $30,000 |
| HIBBS KATHY L | Nov 2, 2023 | Sell | 38,548 | $0.8674 | $33,000 |
| HIBBS KATHY L | Oct 19, 2023 | Sell | 38,548 | $0.8145 | $31,000 |
| HIBBS KATHY L | Oct 5, 2023 | Sell | 38,548 | $0.8407 | $32,000 |
| HIBBS KATHY L | Sep 21, 2023 | Sell | 38,548 | $1.0009 | $39,000 |
| HIBBS KATHY L | Sep 7, 2023 | Sell | 40,894 | $1.0633 | $43,000 |
| Richards William G | Sep 5, 2023 | Sell | 2,538 | $1.08 | $2,700 |
| HIBBS KATHY L | Aug 24, 2023 | Sell | 40,894 | $1.0544 | $43,000 |
| HIBBS KATHY L | Aug 15, 2023 | Sell | 40,894 | $1.319 | $54,000 |
| HIBBS KATHY L | Jul 27, 2023 | Sell | 40,894 | $1.8892 | $77,000 |
| HIBBS KATHY L | Jul 13, 2023 | Sell | 40,894 | $1.8154 | $74,000 |
| HIBBS KATHY L | Jun 29, 2023 | Sell | 40,894 | $1.7223 | $70,000 |
What's the latest insider transaction for 23andMe?
The most recent insider transaction for 23andMe was conducted by HIBBS KATHY L, who sold 38,551 shares on May 2, 2024 at a price of $0.49 per share.
Which insider has sold the most ME stock over the last two years?
HIBBS KATHY L has sold the most ME stock in the last 2 years, with a total value of $840,000.
What is the total value of insider transactions for 23andMe (ME) in the last 2 years?
The total value of insider transactions for 23andMe in the last 2 years is negative, amounting to -$840,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on 23andMe's market confidence?
Over the last 2 years, insider transactions for 23andMe have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
